| |
Live rat
|
Bottled rat blood with anticoagulant
|
|---|
|
Defibrinated
|
Na citrate
|
Na heparin
|
EDTA
|
|---|
|
Proportion of replete females1
|
46/100
|
67/100
|
66/100
|
61/100
|
59/100
|
|
Ingested blood (mg) per female
|
2.90±0.94a
|
2.45±0.32a
|
2.27±0.33a
|
2.15±0.64a
|
1.26±0.55b
|
|
Females examined for time to oviposition and eggs laid2
|
20
|
8
|
20
|
18
|
10
|
|
Time to oviposition (days)3
|
3.90 ± 0.85a
|
3.50 ± 1.41a, b
|
3.60 ± 0.50a,b
|
3.28 ± 0.9a,b
|
3.00 ± 0.00b
|
|
Total eggs per female
|
123.2 ± 48.0
|
140.6 ± 37.7
|
110.0 ± 44.7
|
115.3 ± 48.4
|
137.4 ± 25.1
|
|
Eggs per mg blood consumed3
|
46.7 ± 21.0a
|
57.9 ± 15.5a, b
|
49.2 ± 20.0a
|
57.6 ± 26.1a,b
|
69.0 ± 12.6b
|
- 1Females were fed in cohorts of 10 per cage for a total of 100 females per treatment. χ2 = 11.76, df= 4, p= 0.02
- 2A subsample of replete females was examined to determine time to oviposition, total eggs per female (clutch size) and eggs per mg of blood consumed
- 3For each indicated row, the mean ± SD for each treatment is indicated. Different small case letters after a given mean indicates treatments significantly differed from one another after ANOVA or Kruskal-Wallis and post hoc Tukey Kramer or Dunn’s tests, respectively
- Different letters to the right of means in each row indicated the treatments significantly differed from one another (p ≤ 0.05).
